Concentration of inhaled amiloride in cystic fibrosis [21]

Lancet

Volumn 347, Issue 9008, 1996, Pages 1126-

  Visca, A ^a   Bignamini, E ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LETTER; LUNG FUNCTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

EID: 0029988412     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90329-3     Document Type: Letter

References (3)

1. Mj Stutts Cm Canessa Jc Olsen M. Hamrick Ja Cohn CFTR as a cAMP-dependent regulator of sodium channels Science 269 1995 847 50
2. A. Graham A. Hasani Efwf Alton No added benefit from nebulized amiloride in patients with cystic fibrosis Eur Respir J 6 1993 1243 1248
3. G. Huels H. Lindemann T. Hofmann I. Senier P. Bittner Hj Schwandt Cystic fibrosis: is aerosolized amiloride optimally used? Eur Respir J 8 1995 574